- Home
- Publications
- Publication Search
- Publication Details
Title
Incidence and Burden of the Myelodysplastic Syndromes
Authors
Keywords
Myelodysplastic syndromes, Epidemiology, Incidence, Prevalence
Journal
Current Hematologic Malignancy Reports
Volume 10, Issue 3, Pages 272-281
Publisher
Springer Nature
Online
2015-07-01
DOI
10.1007/s11899-015-0269-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study
- (2014) Zoe K. McQuilten et al. CANCER
- Radiation Alone for Solid Tumors and the Questionable Development of Therapy-Related Myelodysplastic Syndromes
- (2014) C. R. Cogle JNCI-Journal of the National Cancer Institute
- Risk for Developing Myelodysplastic Syndromes in Prostate Cancer Patients Definitively Treated With Radiation
- (2014) Sudipto Mukherjee et al. JNCI-Journal of the National Cancer Institute
- Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS)
- (2014) Hajime Uno et al. LEUKEMIA RESEARCH
- Age-related mutations associated with clonal hematopoietic expansion and malignancies
- (2014) Mingchao Xie et al. NATURE MEDICINE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poor Outcome of Patients With Myelodysplastic Syndrome After Azacitidine Treatment Failure
- (2013) Vu H. Duong et al. Clinical Lymphoma Myeloma & Leukemia
- Health care utilization and risk of infection and bleeding among patients with myelodysplastic syndromes with/without transfusions, and with/without active therapy
- (2013) B. Douglas Smith et al. LEUKEMIA & LYMPHOMA
- High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment
- (2013) Christopher R. Cogle et al. LEUKEMIA RESEARCH
- Myelodysplastic syndrome incidence, transfusion dependence, health care use, and complications: an Australian population-based study 1998 to 2008
- (2013) Zoe K. McQuilten et al. TRANSFUSION
- Epidemiology of Myelodysplastic Syndromes
- (2012) Xiaomei Ma AMERICAN JOURNAL OF MEDICINE
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Underreporting of Myeloid Malignancies by United States Cancer Registries
- (2012) B. M. Craig et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes
- (2012) Rong Wang et al. LEUKEMIA RESEARCH
- Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need
- (2012) Stuart L. Goldberg et al. TRANSFUSION
- Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries
- (2011) C. R. Cogle et al. BLOOD
- A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
- (2011) P. Fenaux et al. BLOOD
- Anemia in older persons: Etiology and evaluation
- (2011) Elizabeth A. Price et al. BLOOD CELLS MOLECULES AND DISEASES
- Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure
- (2011) Thomas Prébet et al. JOURNAL OF CLINICAL ONCOLOGY
- Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group
- (2011) Michael Lübbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registry
- (2011) Judith Neukirchen et al. LEUKEMIA RESEARCH
- Failure of Hypomethylating Agent–Based Therapy in Myelodysplastic Syndromes
- (2011) Tapan M. Kadia et al. SEMINARS IN ONCOLOGY
- PCN33 COST SAVINGS ASSOCIATED WITH TRANSFUSION INDEPENDENCE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH A 5Q- DELETION
- (2011) D. Bozkaya et al. VALUE IN HEALTH
- Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006
- (2010) Anneclaire J. De Roos et al. AMERICAN JOURNAL OF HEMATOLOGY
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
- (2010) M. Sant et al. BLOOD
- Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy
- (2010) Elias Jabbour et al. CANCER
- Effects of azacitidine compared with conventional care regimens in elderly (≥75 years) patients with higher-risk myelodysplastic syndromes
- (2010) John F. Seymour et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Incidence of myelodysplastic syndromes in a Swedish population
- (2010) Anders Rådlund et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States Medicare Beneficiaries
- (2010) Stuart L. Goldberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes
- (2010) Rong Wang et al. LEUKEMIA RESEARCH
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders
- (2009) Thomas E. Delea et al. CURRENT MEDICAL RESEARCH AND OPINION
- Estimation of economic costs associated with transfusion dependence in adults with MDS
- (2009) Jennifer R. Frytak et al. CURRENT MEDICAL RESEARCH AND OPINION
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: A retrospective study of 322 bone marrows
- (2009) Rena Buckstein et al. LEUKEMIA RESEARCH
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
- (2008) D. E. Rollison et al. BLOOD
- Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes
- (2008) Elias Jabbour et al. CANCER
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
- (2008) Hagop Kantarjian et al. CANCER
- Characteristics of US Patients with Myelodysplastic Syndromes: Results of Six Cross-sectional Physician Surveys
- (2008) Mikkael A. Sekeres et al. JNCI-Journal of the National Cancer Institute
- Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine
- (2008) Gautam Borthakur et al. LEUKEMIA & LYMPHOMA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started